2012 Vol.30, N°2 - Suppl.71 - Table of contents

Scleroderma Care and Research - May 2012

Guest Editors: P.J. Clements, M. Matucci-Cerinic, J.R. Seibold

A bird's eye review of the recent literature

CER5729
2012,30,2,Suppl.71
Pg. 0003-0006

Free to view

Systemic sclerosis. A bird`s eye review of the recent literature
A. Della Rossa

Full Papers

CER4533
2012,30,2,Suppl.71
Pg. 0007-0011

Free to view

Vaccination against influenza in patients with systemic sclerosis
I. Litinsky, A. Balbir, D. Zisman, M. Mandelboim, E. Mendelson, J. Feld, Y. Braun, M. Anouk, I. Kaufman, D. Paran, D. Caspi, O. Elkayam

CER3727
2012,30,2,Suppl.71
Pg. 0012-0016

Free to view

Anti-PM-Scl antibody in patients with systemic sclerosis
R.W. Koschik, N. Fertig, M.R. Lucas, R.T. Domsic, T.A. Medsger

CER4517
2012,30,2,Suppl.71
Pg. 0017-0022

Free to view

Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis
D. Daoussis, S.-N. Liossis, A.C. Tsamandas, C. Kalogeropoulou, F. Paliogianni, C. Sirinian, G. Yiannopoulos, A.P. Andonopoulos

CER4716
2012,30,2,Suppl.71
Pg. 0023-0029

Free to view

New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN)
B.D. Thombs, L.R. Jewett, S. Assassi, M. Baron, S.J. Bartlett, A.C. Maia, G. El-Baalbaki, D.E. Furst, K. Gottesman, J.A. Haythornthwaite, M. Hudson, A. Impens, A. Korner, C. Leite, M.D. Mayes, V.L. Malcarne, S.J. Motivala, L. Mouthon, W.R. Nielson, D. Plante, S. Poiraudeau, J.L. Poole, J. Pope, M. Sauve, R.J. Steele, M.E. Suarez-Almazor, S. Taillefer, C.H. Van Den Ende, E. Arthurs, M. Bassel, V. Delisle, K. Milette, A. Leavens, I. Razykov, D. Khanna

CER4565
2012,30,2,Suppl.71
Pg. 0030-0037

Free to view

Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis
M. Hinchcliff, C.S. Desai, J. Varga, S.J. Shah

CER4542
2012,30,2,Suppl.71
Pg. 0038-0043

Free to view

Best practices in scleroderma: an analysis of practice variability in SSc centres within the Canadian Scleroderma Research Group (CSRG)
S. Harding, S. Khimdas, A. Bonner, M. Baron, J. Pope

CER4443
2012,30,2,Suppl.71
Pg. 0044-0049

Free to view

CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment
F. Bandinelli, A. Del Rosso, A. Gabrielli, R. Giacomelli, F. Bartoli, S. Guiducci, M. Matucci Cerinic

CER5063
2012,30,2,Suppl.71
Pg. 0050-0054

Free to view

Assessment of capillary density in systemic sclerosis with three different capillaroscopic methods
M. Wildt, D.M. Wuttge, R. Hesselstrand, A. Scheja

CER5101
2012,30,2,Suppl.71
Pg. 0055-0059

Free to view

Long-term safety and effectiveness of tumour necrosis factor inhibitors in systemic sclerosis patients with inflammatory arthritis
M.A. Omair, V. Phumethum, S.R. Johnson

CER5266
2012,30,2,Suppl.71
Pg. 0060-0066

Free to view

Prevalence and clinical importance of gastroesophageal reflux in Chinese patients with systemic sclerosis
X. Liu, M. Li, D. Xu, Y. Hou, Q. Wang, Z. Tian, Q. Sun, X. Zeng

CER5183
2012,30,2,Suppl.71
Pg. 0067-0070

Free to view

Different microvascular involvement in dermatomyositis and systemic sclerosis. A preliminary study by a tight videocapillaroscopic assessment
R. De Angelis, M. Cutolo, M. Gutierrez, C. Bertolazzi, F. Salaffi, W. Grassi

CER4208
2012,30,2,Suppl.71
Pg. 0071-0075

Free to view

CXCL11 in bronchoalveolar lavage fluid and pulmonary function decline in systemic sclerosis
P. Sfriso, F. Cozzi, F. Oliviero, F. Caso, S. Cardarelli, M. Facco, C. Fittà, A. Del Rosso, M. Matucci-Cerinic, L. Punzi, C. Agostini

CER5245
2012,30,2,Suppl.71
Pg. 0076-0080

Free to view

Macrovascular involvement in systemic sclerosis: evidence of correlation with disease activity
Y. Zeng, M. Li, D. Xu, Y. Hou, Q. Wang, Q. Fang, Q. Sun, S. Zhang, X. Zeng

CER5251
2012,30,2,Suppl.71
Pg. 0081-0085

Free to view

Role of N-terminal pro-brain natriuretic peptide in detecting clinically significant cardiac involvement in systemic sclerosis patients
C. Chighizola, P.L. Meroni, B.E. Schreiber, J.G. Coghlan, C.P. Denton, V.H. Ong

CER5186
2012,30,2,Suppl.71
Pg. 0086-0096

Free to view

Imatinib mesylate causes genome-wide transcriptional changes in systemic sclerosis fibroblasts in vitro
M. Hinchcliff, C.-C. Huang, W. Ishida, F. Fang, J. Lee, N. Jafari, M. Wilkes, S. Bhattacharyya, E. Leof, J. Varga

Review

CER5590
2012,30,2,Suppl.71
Pg. 0097-0102

Free to view

Clinical trial design in scleroderma: where are we and where do we go next?
L. Chung, C.P. Denton, O. Distler, D.E. Furst, D. Khanna, P.A. Merkel

CER5586
2012,30,2,Suppl.71
Pg. 0103-0115

Free to view

Use of infrared thermography as an endpoint in therapeutic trials of Raynaud`s phenomenon and systemic sclerosis
J.D. Pauling, J.A. Shipley, N.D. Harris, N.J. Mchugh

Letter

CER4431
2012,30,2,Suppl.71
Pg. 0116-0117

Free to view

Feet nailfold capillaroscopy is not useful to detect the typical scleroderma pattern.
A. Batticciotto, F. Atzeni, S. Foglia, M. Antivalle, A. Serafin, P. Sarzi-Puttini